2021 | YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation | HEPATOLOGY |
2021 | History and future of hepatitis B virus control in South Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma
| AMERICAN JOURNAL OF CANCER RESEARCH |
2021 | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease
| JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE |
2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2021 | Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2021 | Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | HEPATOLOGY INTERNATIONAL |
2021 | Measuring radiation exposure of operators engaged in the yttrium-90 microsphere radioembolization treatment of hepatocellular carcinoma patients | OPTIK |
2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2021 | Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
| Journal of Liver Cancer(대한간암학회지) |
2021 | Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
2021 | Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy | HEPATOLOGY INTERNATIONAL |
2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2021 | The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2021 | Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma | HPB |
2021 | Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study | DIGESTIVE DISEASES AND SCIENCES |
2021 | Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2021 | Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2021 | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Metabolic activity assessment by 18 F-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals | JOURNAL OF VIRAL HEPATITIS |
2021 | Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
| GUT AND LIVER |
2021 | Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
| GUT AND LIVER |
2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2021 | Current Status of Therapeutic Choice and Feasibility for Patients with Hepatocellular Carcinoma Aged ≥ 70 Years: A Nationwide Cancer Registry Analysis
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2021 | Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B | HEPATOLOGY RESEARCH |
2021 | A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
| Journal of Liver Cancer(대한간암학회지) |
2021 | Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma | CANCER INVESTIGATION |
2021 | Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
| CURRENT ONCOLOGY |
2021 | The case for simplifying and using absolute targets for viral hepatitis elimination goals | JOURNAL OF VIRAL HEPATITIS |
2021 | Epidemiological and Clinical History of Viral Hepatitis in Korea
| INFECTION AND CHEMOTHERAPY |
2021 | Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2021 | Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study | DIGESTIVE DISEASES AND SCIENCES |
2021 | Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
| GUT AND LIVER |
2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2021 | Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir | JOURNAL OF VIRAL HEPATITIS |
2021 | Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
2020 | A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy | JOURNAL OF VIRAL HEPATITIS |
2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2020 | Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study | EUROPEAN JOURNAL OF CANCER |
2020 | Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2020 | The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
| GUT AND LIVER |
2020 | Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
| CANCERS |